OFF/-ON-time changes after switching from entacapone or placebo to opicapone in patients ending the BIPARK-I extension study on opicapone 50-mg

Category Primary study
JournalParkinsonism and Related Disorders
Year 2020
This article has no abstract
Epistemonikos ID: 78c8b12bc3fe0cf1829e8490a0bbeea3318765e7
First added on: Feb 13, 2025